Published in Gene Therapy Weekly, September 1st, 2011
"Subsequent biomaterial-based delivery can increase the vector's residence time within the target site, thereby potentially providing localized...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.